FDA approves Jynarque (tolvaptan) to slow kidney function decline in rapidly progressing autosomal dominant polycystic kidney disease ADPKD. ADPKD is
Tag: Jynarque
stay healthy…
stay healthy…
FDA approves Jynarque (tolvaptan) to slow kidney function decline in rapidly progressing autosomal dominant polycystic kidney disease ADPKD. ADPKD is
